EE vs GSK · P/E 28, rev $1.23B vs P/E 13, $103.31B cap
Excelerate Energy Inc (EE) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Excelerate Energy Inc (EE) is a oil & gas midstream company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported EE revenue for 2025-12-31 was $1.23B. Net income was $167.0M. Revenue was up 44.3% from 2024-12-31 to 2025-12-31. EE currently screens at market cap $3.75B and trailing P/E 27.7.
GSK does not have a complete income-statement cache yet.
EE currently screens at market cap $3.75B and trailing P/E 27.7. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the EE and GSK stock pages for the full models.
Not investment advice.